TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns 
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity 
Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court 
Carro Expands Into Australia With Acquisition of Used-Car Platform CarPlace 
SpaceX Surpasses Amazon in Market Value as Post-IPO Rally Accelerates 
Microsoft Taps AWS to Support GitHub Amid AI Coding Boom 
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples 
Trump Administration Delays DeepSeek and CXMT Trade Blacklist Designations Amid U.S.-China Tensions 
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity 
Jio IPO Filing Nears as Reliance Targets $4 Billion Market Debut 
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures 
Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race 
G7 Explores AI Access Deal With U.S. Amid Anthropic Restrictions 
BHP Shares Fall as Jansen Potash Project Costs Surge 
Trump Says Anthropic No Longer Seen as National Security Threat 
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million 
US Raises Concerns Over Possible ASML EUV Machine Transfer to China 
SCHAUMBURG, Ill., Jan. 08, 2016 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT), a leader of specialty pharmaceutical products with an emphasis on the injectable market, today announced that it will present at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 13, 2016 at 2:00 p.m. PT (4:00 p.m. CT/5:00 p.m. ET). The presentation is being webcast and can be accessed on the "Events and Presentations" page of the "Investor Relations" section of the Company's website, www.sagentpharma.com. In order to register and download any necessary software, please log on 10 minutes prior to the start of the webcast.
A replay of the webcast will be available until Tuesday, February 16, 2016 and can be accessed on the Sagent website.
About Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, Inc., founded in 2006, is a global specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients.
INVESTOR CONTACT: Jonathon Singer, Sagent [email protected] 847-908-1605
